UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
 
 
Filed by the Registrant                               Filed by a Party other than the Registrant  
Check the appropriate box:
  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to §240.14a-12
logo-pearxtherapeuticsxfin.jpg

PEAR THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
  No fee required
  Fee paid previously with preliminary materials
  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11




proxynotice-scrubbed001a.jpg



proxynotice-scrubbed002a.jpg

Grafico Azioni Thimble Point Acquisition (NASDAQ:THMAU)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Thimble Point Acquisition
Grafico Azioni Thimble Point Acquisition (NASDAQ:THMAU)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Thimble Point Acquisition